The effect of peptide stimulation on haematopoietic stem cell mobilisation including engraftment characteristics and a note on donor side effects

Transfusion and Apheresis Science

Volumn 32, Issue 1, 2005, Pages 105-116

  Barendse, Gameda ^a   Tailford, Ruth ^a   Wood, Lucille ^a   Jacobs, Peter ^a  

^a Department of Haematology and Bone Marrow Transplantation Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CITRIC ACID; GLUCONATE CALCIUM; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APHERESIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL GROWTH; CLONOGENIC ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; HEADACHE; HUMAN; LOW BACK PAIN; MONONUCLEAR CELL; NEUTROPHIL; ORGAN DONOR; STEM CELL MOBILIZATION; T LYMPHOCYTE; THORAX PAIN; THROMBOCYTE COUNT;

EID: 14344259569     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.10.010     Document Type: Conference Paper

References (63)

1. P. de Fabritiis, A.P. Iori, A. Mengarelli, M. Gozzer, G. Ferrazza, and M.S. De Propis CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF Transfusion 41 2001 190 195
2. H. Ozer, J.O. Armitage, C.L. Bennett, J. Crawford, G.D. Demetri, and P.A. Pizzo 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines J Clin Oncol 18 2000 3558 3585
3. M. Murata, M. Harada, S. Kato, S. Takahashi, H. Ogawa, and S. Okamoto Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors Bone Marrow Transplant 24 1999 1065 1071
4. C. Sachse, and E. Henkel An evaluation of the CELL-DYN 1700 haematology analyzer: automated cell counting and three-part leucocyte differentiation Clin Lab Haematol 18 1996 171 180
5. A.R. Jones, D. Twedt, and R. Hellman Absolute versus proportional differential leucocyte counts Clin Lab Haematol 17 1995 115 123
6. P. Dreger, T. Haferlach, V. Eckstein, S. Jacobs, M. Suttorp, and H. Löffler G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft Br J Haematol 87 1994 609 613
7. D.R. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-Yee The ISHAGE guidelines for CD34+ cell determination by flow cytometry J Hematother 5 1996 213 226
8. I. McNiece, B. Kern, K. Zilm, C. Brunaud, G. Dziem, and R. Bridell Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodology J Hematother 7 1998 499 504
9. H.G. Heuft, M. Dubiel, D. Kingreen, J. Oertel, S. De Reys, and O. Rick Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation Vox Sang 79 2000 94 99
10. P. Jacobs, L. Wood, L. Fullard, H. Waldmann, and G. Hale T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease Bone Marrow Transplant 13 1994 763 769
11. + cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use Bone Marrow Transplant 17 1996 259 264
12. H. Bittencourt, V. Rocha, S. Chevret, G. Socié, H. Espérou, and A. Devergie Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation Blood 99 2002 2726 2733
13. S. Shenoy, T. Mohanakumar, G. Todd, W. Westhoff, K. Dunnigan, and D.R. Adkins Immune reconstitution following allogeneic peripheral blood stem cell transplants Bone Marrow Transplant 23 1999 335 346
14. H.M. van der Straaten, R. Fijnheer, A.W. Dekker, H.K. Nieuwenhuisen, and L.F. Verdonck Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation Br J Haematol 114 2001 31 35
15. L. Wood, J. Richards, and P. Jacobs The role of the professional nurse in a bone marrow transplantation programme Curationis 13 1990 77 84
16. L. Wood, J.D. Richards, and P. Jacobs The professional nurse in the cell support unit Curationis 7 1984 30 33
17. R. Jones, and A.K. Burnett How to harvest bone marrow for transplantation J Clin Pathol 45 1992 1053 1057
18. R. Moog, and N. Müller Technical aspects and performance in collecting peripheral blood progenitor cells Ann Hematol 77 1998 143 147
19. I.W. Blau, N. Basara, G. Lentini, S. Guenzelmann, D. Kirsten, and B. Schmetzer Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study Bone Marrow Transplant 27 2001 27 33
20. J. Luider, C. Brown, S. Selinger, D. Quinlan, L. Karlsson, and D. Ruether Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis J Hematother 6 1997 13 19
21. R. Bosse, P. Kulmburg, C. von Kalle, M. Engelhardt, A. Dwenger, F. Rosenthal, and G. Schulz Production of stem-cell transplants according to good manufacturing practice Ann Hematol 79 2000 469 476
22. T.J. Farley, W. Rooney, E. Kuhns, T. Ahmed, and R.A. Preti An intralaboratory quality control program for quantitation of CD34+ cells by flow cytometry J Hematother 6 1997 303 308
23. K. Hübel, D.C. Dale, and W.C. Liles Granulocyte transfusion therapy: update on potential clinical applications Curr Opin Hematol 8 2001 161 164
24. D. Blaise, M. Kuentz, C. Fortanier, J.H. Bourhis, N. Milpied, and L. Sutton Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle J Clin Oncol 18 2000 537 546
25. E. Olavarria, and E.J. Kanfer Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells Curr Opin Hematol 7 2000 191 196
26. F. de Boer, A.M. Dräger, M.J.A.M. van Haperen, E. van der Wall, E. Kessler, and P.C. Huijgens The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens Br J Haematol 111 2000 1138 1144
27. M. Gyger, R.K. Stuart, and C. Perreault Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor Bone Marrow Transplant 26 2000 1 16
28. G. Gürman, I. Dilek, Ö. Arslan, M. Arat, M. Beksaç, and O. Ilhan The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cells transplantation Transfus Apheresis Sci 24 2001 23 28
29. H. Tayebi, F. Kuttler, P. Saas, A. Lienard, B. Petracca, and V. Lapierre Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells Exp Hematol 29 2001 458 470
30. C. Martínez, A. Urbano-Ispizua, P. Marín, A. Merino, M. Rovira, E. Carreras, and E. Montserrat Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors Bone Marrow Transplant 24 1999 1273 1278
31. J. de la Rubia, C. Martínez, C. Solano, S. Brunet, P. Cascón, and R. Arrieta Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish Donor Registry Bone Marrow Transplant 24 1999 723 728
32. F. Gutierrez-Delgado, and W. Bensinger Safety of granulocyte colony-stimulating factor in normal donors Curr Opin Hematol 8 2001 155 160
33. A.M. Cavallaro, K. Lilleby, I. Majolino, R. Storb, F.R. Appelbaum, S.D. Rowley, and W.I. Bensinger Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor Bone Marrow Transplant 25 2000 85 89
34. J.P. Lévesque, J. Hendy, Y. Takamatsu, B. Williams, I.G. Winkler, and P.J. Simmons Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment Exp Hematol 30 2002 440 449
35. C. Martínez, A. Urbano-Ispizua, M. Rozman, M. Rovira, P. Marín, and N. Montfort Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors Bone Marrow Transplant 23 1999 15 19
36. P. Klangsinsirikul, and N.H. Russell Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells Exp Hematol 30 2002 495 501
37. T. Watanabe, T. Kajiume, T. Abe, Y. Kawano, A. Iwai, and T. Iwai Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings Med Pediatr Oncol 34 2000 171 176
38. A. Mijovic, A. Pagliuca, and G.J. Mufti The G-CSF test: the response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies Exp Hematol 27 1999 1204 1209
39. M.S. Krieger, G. Schiller, J.R. Berenson, K. Stewart, S.J. Noga, and O. Ballester Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells Bone Marrow Transplant 24 1999 25 28
40. K. Theilgaard-Mönch, K. Raaschou-Jensen, H. Andersen, C.A. Russell, L. Vindeløv, N. Jacobsen, and E. Dickmeiss Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain 10-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts Bone Marrow Transplant 23 1999 243 249
41. C.H. Weaver, K.A. Schulman, B. Wilson-Releyea, R. Birch, W. West, and C.D. Buckner Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells J Clin Oncol 18 2000 43 53
42. M.J. Horsfall, C.H. Hui, L.B. To, C.G. Begley, R.L. Basser, and P.J. Simmons Combination of stem cell factor and granulocyte colony-stimulating factor mobilizes the highest number of primitive haemopoietic progenitors as shown by pre-colony-forming unit (pre-CFU) assay Br J Haematol 109 2000 751 758
43. S.B. Burger, D. Kadidlo, and J. McCullough Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor Transfusion 39 1999 451 456
44. C. Jacquy, A. Sorée, F. Lambert, A. Bosly, A. Ferrant, and M. André A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells Br J Haematol 110 2000 631 637
45. A. Kessinger, M.R. Bishop, J.R. Anderson, J.O. Armitage, P.J. Bierman, and E.C. Reed Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization J Hematother 4 1995 81 84
46. W. Chaisiripoomkere, S. Jootar, and A. Ungkanont Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors Asian Pac J Allergy Immunol 19 2001 183 190
47. J. Jansen, J.M. Thompson, M.J. Dugan, P. Nolan, M.C. Wiemann, and R. Birhiray Peripheral blood progenitor cell transplantation Ther Apher 6 2002 5 14
48. J.A. Perez-Simon, M.D. Caballero, M. Corral, M.J. Nieto, A. Orfao, and L. Vazquez Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation Transfusion 38 1998 385 391
49. A. Bacigalupo, G. Piaggio, M. Podesta, O. Figari, F. Benvenuto, and G. Sogno Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation Bone Marrow Transplant 15 1995 221 226
50. + cells? Blood 98 2001 2352 2357
51. A. Toubert, and D. Charron Immune reconstitution after hematopoietic stem cell transplantation: gaining experience without losing naivety Hum Immunol 62 2001 500 503
52. S. Chakrabarti, D. McDonald, and D.W. Milligan T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft? Bone Marrow Transplant 28 2001 313 314
53. M.A. Lumley, A. Burton, L.J. Billingham, D.F. McDonald, H.M. Czarnecka, and D.W. Milligan Quality assurance of CFU-GM assays: inter-laboratory variation despite standard reagents Eur J Haematol 62 1999 32 37
54. + cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma Br J Haematol 104 1999 374 381
55. D. Gaziev, G. Lucarelli, P. Polchi, E. Angelucci, M. Galimberti, and C. Giardini A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease Bone Marrow Transplant 27 2001 45 51
56. G. Hale, P. Jacobs, L. Wood, W.E. Fibbe, R. Barge, and N. Novitzky CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells Bone Marrow Transplant 26 2000 69 76
57. M.W. Lowdell, R. Craston, N. Ray, M. Koh, G. Galatowicz, and H.G. Prentice The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia Bone Marrow Transplant 21 1998 679 686
58. C. Barbot, A. Rice, I. Vanes, F.X. Mahon, B. Jazwiec, and J. Reiffers Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients Nouv Rev Fr Hematol 36 1994 325 331
59. N. Novitzky, and R. Mohamed Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation Exp Hematol 23 1995 1661 1666
60. C.A. Dykewicz Preventing opportunistic infections in bone marrow transplant recipients Transplant Infect Dis 1 1999 40 49
61. D. Avigan, L.A. Pirofsky, and H.M. Lazarus Vaccination against infectious disease following hematopoietic stem cell transplantation Biol Blood Marrow Transplant 7 2001 171 183
62. J.H. Antin Acute graft-versus-host disease: inflammation run amok J Clin Invest 107 2001 1497 1498
63. D.Y. Wu, and I. Goldschneider Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants J Immunol 162 1999 6926 6933